DGAP-News: STADA Arzneimittel AG / Key word(s): Bond
18.09.2018 / 15:07
The issuer is solely responsible for the content of this announcement.
Bad Vilbel, 18 September 2018 – STADA Arzneimittel Aktiengesellschaft (“STADA” or the “Issuer“) today informed about the voting results of the meeting on 18 September 2018 (the “Bondholders’ Meeting“) of the bondholders (the “Bondholders“) of the EUR 300,000,000 1.750% bonds, due 2022, ISIN: XS1213831362, Common Code: 121383136, WKN: A14KJP (the “Bond“).
The purpose of today’s meeting was to set the basis for the Bondholders to participate in certain security interests. It was planned to pass a resolution on the instruction of the joint representative of the Bondholders to accede to the intercreditor agreement and on certain technical changes to the Bond’s terms and conditions.
Since the Bondholders’ Meeting did not reach the quorum required for the resolutions on these agenda items, no resolutions could be passed.
Further details of the Bondholders’ Meeting are available on the STADA website at www.stada.com/investor-relations/bonds.html.
About STADA Arzneimittel AG
Additional information for journalists:
Additional information for capital market participants:
18.09.2018 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||STADA Arzneimittel AG|
|61118 Bad Vilbel|
|Phone:||+49 (0)6101 603-4689|
|Fax:||+49 (0)6101 603- 215|
|Listed:||Regulated Market in Dusseldorf, Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|End of News||DGAP News Service|